Key takeaways MeAgain ranks #1 as the best all-in-one GLP-1 tracker app of 2026: shots or pills, injection sites, five food-logging methods, 18 common side effects plus unlimited custom symptoms, weight, progress photos, an estimated medication-level graph, and the Capy companion rated 4.8 from 25K App Store ratings, on iPhone, iPad, and Android
The double-blind, placebo-controlled, event-driven superiority trial included 9,650 participants who were 50 years of age or older
Comprehending an individual's genetic differences enables personalised dietary, lifestyle, and hormonal interventions
[1] The Medicines and Healthcare products Regulatory Agency (MHRA) has approved semaglutide based on robust clinical evidence demonstrating its efficacy in glycaemic control and, for Wegovy, weight reduction